
LENSAR LNSR
$ 5.56
0.0%
Quarterly report 2025-Q3
added 11-06-2025
LENSAR Interest Expense 2011-2026 | LNSR
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense LENSAR
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 660 K | 698 K | 263 K | 51 K | 1.34 M | 2 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2 M | 51 K | 836 K |
Quarterly Interest Expense LENSAR
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 133 K | 193 K | 159 K | - | 153 K | 160 K | 198 K | - | 265 K | 111 K | 89 K | - | 92 K | 39 K | 9 K | - | 10 K | 13 K | 18 K | - | 65 K | 671 K | 604 K | - | 494 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 671 K | 9 K | 183 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
45.9 M | $ 11.75 | - | $ 1.76 B | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Delcath Systems
DCTH
|
-70 K | $ 8.98 | - | $ 322 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.41 | - | $ 121 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.01 | - | $ 1.22 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Inogen
INGN
|
2.44 M | $ 6.32 | - | $ 168 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 100.97 | - | $ 1.28 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
LivaNova PLC
LIVN
|
664 K | $ 62.4 | - | $ 3.4 B | ||
|
AxoGen
AXGN
|
167 K | $ 32.61 | - | $ 1.5 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.56 | - | $ 1.13 B | ||
|
Medtronic PLC
MDT
|
402 M | $ 86.58 | - | $ 111 B | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
Electromed
ELMD
|
78 K | $ 24.7 | - | $ 209 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Aethlon Medical
AEMD
|
10.1 K | $ 2.16 | - | $ 3.37 M | ||
|
InspireMD
NSPR
|
200 K | $ 1.79 | 3.47 % | $ 115 M | ||
|
Profound Medical Corp.
PROF
|
146 K | $ 5.15 | - | $ 180 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Orthofix Medical
OFIX
|
8.11 M | $ 11.72 | - | $ 464 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 11.48 | - | $ 1.55 B | ||
|
Myomo
MYO
|
-668 K | $ 0.7 | - | $ 29.3 M | ||
|
Penumbra
PEN
|
893 K | $ 334.17 | - | $ 13 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.91 | - | $ 146 M | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 225.5 | - | $ 15.9 B | ||
|
Quanterix Corporation
QTRX
|
157 K | $ 3.82 | - | $ 163 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 15.91 | - | $ 373 M |